Alendronate

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Year introduced: 1997 (1987)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D02.705.429.500.100

MeSH Unique ID: D019386

Registry Number: X1J18R4W8P

Entry Terms:

• 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
• Aminohydroxybutane Bisphosphonate
• MK-217
• MK 217
• MK217
• Alendronate Monosodium Salt, Trihydrate
• Alendronate Sodium
• Fosamax

Previous Indexing:

• Diphosphonates (1987-1996)

Pharmacologic Action:

• Bone Density Conservation Agents

All MeSH Categories
Chemicals and Drugs Category
Organic Chemicals
Organophosphorus Compounds
Organophosphonates
Diphosphonates
Alendronate